BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31902110)

  • 1. MiR-873, as a suppressor in cervical cancer, inhibits cells proliferation, invasion and migration via negatively regulating ULBP2.
    Liang HX; Li YH
    Genes Genomics; 2020 Apr; 42(4):371-382. PubMed ID: 31902110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-34b-3p-mediated regulation of STC2 and FN1 enhances chemosensitivity and inhibits proliferation in cervical cancer.
    Jin S; Wang W; Xu X; Yu Z; Feng Z; Xie J; Lv H
    Acta Biochim Biophys Sin (Shanghai); 2024 May; 56(5):740-752. PubMed ID: 38477044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The miR-133b/brefeldin A-inhibited guanine nucleotide-exchange protein 1 (ARFGEF1) axis represses proliferation, invasion, and migration in cervical cancer cells.
    Jiang L; Wang X
    Bioengineered; 2022 Feb; 13(2):3323-3332. PubMed ID: 35048795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-505-5p functions as a tumor suppressor by targeting cyclin-dependent kinase 5 in cervical cancer.
    Kapora E; Feng S; Liu W; Sakhautdinova I; Gao B; Tan W
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31266812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LINC01605 promotes malignant phenotypes of cervical cancer via miR-149-3p/WNT7B axis.
    Kong X; Xiong Y; Li L
    Gene; 2024 Aug; 921():148518. PubMed ID: 38734188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibition of miR-126 in cell migration and invasion of cervical cancer through regulating ZEB1.
    Xu J; Wang H; Wang H; Chen Q; Zhang L; Song C; Zhou Q; Hong Y
    Hereditas; 2019; 156():11. PubMed ID: 31007650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced long non-coding RNA PTENP1 contributed to proliferation and invasion via miR-19b/MTUS1 axis in patients with cervical cancer.
    Ou L; Xiang TY; Hao XY; Wang DZ; Zeng Q
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4132-4144. PubMed ID: 32373949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
    Li YM; Li XJ; Yang HL; Zhang YB; Li JC
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
    Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
    Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential suppressive functions of microRNA-504 in cervical cancer cells malignant process were achieved by targeting PAICS and regulating EMT.
    Qu ZY; Cui GY; Shi PJ; Wang HQ
    Arch Gynecol Obstet; 2020 Jul; 302(1):173-182. PubMed ID: 32417959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of miRNA-148a inhibits proliferation, invasion, and migration while promoting apoptosis of cervical cancer cells by down-regulating RRS1.
    Zhang Y; Sun B; Zhao L; Liu Z; Xu Z; Tian Y; Hao C
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30910849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-374b inhibits cervical cancer cell proliferation and induces apoptosis through the p38/ERK signaling pathway by binding to JAM-2.
    Li GC; Cao XY; Li YN; Qiu YY; Li YN; Liu XJ; Sun XX
    J Cell Physiol; 2018 Sep; 233(9):7379-7390. PubMed ID: 29575013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-1266 promotes cell proliferation, migration and invasion in cervical cancer by targeting DAB2IP.
    Wang J; Liu Y; Wang X; Li J; Wei J; Wang Y; Song W; Zhang Z
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3623-3630. PubMed ID: 30261286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA ASB16-AS1 enhances cell proliferation, migration and invasion via functioning as a ceRNA through miR-1305/Wnt/β-catenin axis in cervical cancer.
    Liu W; Zhuang R; Feng S; Bai X; Jia Z; Kapora E; Tan W
    Biomed Pharmacother; 2020 May; 125():109965. PubMed ID: 32058219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CircRNA8924 Promotes Cervical Cancer Cell Proliferation, Migration and Invasion by Competitively Binding to MiR-518d-5p /519-5p Family and Modulating the Expression of CBX8.
    Liu J; Wang D; Long Z; Liu J; Li W
    Cell Physiol Biochem; 2018; 48(1):173-184. PubMed ID: 30007986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-520d-5p functions as a tumor-suppressor gene in cervical cancer through targeting PTK2.
    Zhang L; Liu F; Fu Y; Chen X; Zhang D
    Life Sci; 2020 Aug; 254():117558. PubMed ID: 32198053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation.
    Dong P; Xiong Y; Hanley SJB; Yue J; Watari H
    J Exp Clin Cancer Res; 2017 Oct; 36(1):150. PubMed ID: 29073938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-137 is negatively associated with clinical outcome and regulates tumor development through EZH2 in cervical cancer.
    Zhang H; Yan T; Liu Z; Wang J; Lu Y; Li D; Liang W
    J Cell Biochem; 2018 Jan; 119(1):938-947. PubMed ID: 28681918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-106b is involved in transforming growth factor β1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma.
    Cheng Y; Guo Y; Zhang Y; You K; Li Z; Geng L
    J Exp Clin Cancer Res; 2016 Jan; 35():11. PubMed ID: 26769181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-4319 targets tuftelin 1 to reduce malignancy of cervical cancer cells.
    Zheng L; Ren Q; Zhu W; Tao X; Guo L
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):54-60. PubMed ID: 38650156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.